Andrew J. Murphy - 09 Dec 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research
Signature
/s/**Andrew Murphy
Issuer symbol
REGN
Transactions as of
09 Dec 2022
Net transactions value
-$370,614
Form type
4
Filing time
13 Dec 2022, 15:12:02 UTC
Previous filing
16 Nov 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability $370,614 -492 -0.86% $753.28 56,618 09 Dec 2022 Direct
holding REGN Common Stock 4,290 09 Dec 2022 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.